Medical Clinics of North America-Periprocedural Antithrombotics: Prophylaxis and Interruption
Recommended Citation
Wilson SJ, Gelovani D, Von A, Kaatz S, and Grant PJ. Medical Clinics of North America-Periprocedural Antithrombotics: Prophylaxis and Interruption. Med Clin North Am 2024; 108(6):1017-1037.
Document Type
Article
Publication Date
11-1-2024
Publication Title
The Medical clinics of North America
Abstract
Anticoagulation management in the surgical patient requires clinical expertise and careful attention. For patients already receiving anticoagulation for a defined indication (ie, stroke prevention for atrial fibrillation, treatment of venous thromboembolism (VTE), or presence of a mechanical heart valve), understanding how to manage these agents by weighing the risks of thromboembolic events and bleeding is paramount. Additionally, prevention of VTE in the surgical patient involves the identification of patient-specific and procedure-specific risk factors for both VTE and bleeding. With this information, as well as familiarity with the several antithrombotic options available, an appropriate prophylaxis strategy can be employed.
Medical Subject Headings
Humans; Venous Thromboembolism; Fibrinolytic Agents; Anticoagulants; Risk Factors; Hemorrhage; Atrial Fibrillation; Perioperative Care
PubMed ID
39341611
Volume
108
Issue
6
First Page
1017
Last Page
1037
